Remarks: Clarithromycin for the semi-synthetic macrolide antibiotic, with bacterial 50S ribosomal subunits, thus inhibiting its role in protein synthesis and antibiotic production
None of the products will be supplied to countries in which this could be in conflict with the existing patents. However the final responsibility lies with the Buyer.